top
Please input keywords
OK
ニュース&PR
お問い合わせ
JP
CN
EN
KR
About us
会社情報
私たちの歩み
管理スタッフ
企業文化
社会的責任
共に働く
研究提携
Antibody Assets
Project Integrum
Antibody discovery platforms
Pipeline
Clinical pipeline
Preclinical pipeline
RenMice
RenMab
RenLite
RenNano
動物・細胞モデル
Humanized animal models
KO mouse models
Tool mice
Immunodeficient mice/rats
Cell lines
Aged mice
Disease mouse models
Pharmacology service
Therapeutic area
Types of services
Molecule type
Technology
ゲノム編集
By species
By technologies
By strategies
Animal Breeding
Animal Cryopreservation
Animal Rederivation
Other Services
Microbial detection
Animal Breeding
Animal Cryopreservation
Animal Rederivation
IR
Stock Information
Financial Reports
Listing Documents
Announcements & Notices
Corporate Governance
Investor Calendar
Email Alert
IR Contact
Home
News events
資料ダウンロード
ポスターダウンロード
ニュース & PR
世界に通用する跳躍
ニュースリリース
キャンペーン一覧
ウェビナー
発表論文一覧
資料ダウンロード
ポスターダウンロード
製品資料ダウンロード
2024
AACR 2024: A first-in-class bispecific ADC targeting FOLR1 and MUC1 exhibits promising anti-tumor activity in a FOLR1low xenograft model
2024
AACR 2024: BCG033, a novel bispecific antibody-drug conjugate targeting PTK7 and TROP2, demonstrates preclinical efficacy against triple-negative breast cancer and other solid tumor xenografts
2024
AACR 2024: TIL analysis demonstrates different mechanisms underlying PD-1 resistance in animal models
2024
AACR 2024: Generation of a novel severely immunodeficient Sprague Dawley rat model for xenograft studies
2024
AACR 2024: A novel humanized NKP46 mouse model to support xenograft studies evaluating NK cell-based cancer immunotherapies
2024
AACR 2024: A novel humanized CD16A model to evaluate efficacy of human antibody therapeutics in triggering ADCC
2024
AACR 2024: Development and validation of humanized HLA mouse model platforms for preclinical evaluation of novel peptide vaccines
2024
AACR 2024: Establishment of a humanized IL5/IL5RA mouse model to evaluate modulators of eosinophilic inflammation in vivo
2024
AACR 2024: Development of humanized VEGFA models to assess preclinical efficacy of novel therapeutics in vivo
1
2
3
4
5
…
12
GO